DR

Nov 25 2024ENVIRONMENT

Alaska's Beach Bounce Back: How Infauna Thrived After Oil Spill Cleanup

In 1989, the Exxon Valdez oil spill wreaked havoc on Alaska's Prince William Sound. Cleanup efforts involved blasting the beaches with high-pressure, heated water to remove the oil. Scientists worried about the long-term effects on the beach habitats. Nine years later, a study checked in on these be

reading time less than a minute
Nov 24 2024HEALTH

Drinking On The Rise: Pandemic's Lasting Impact

The Covid-19 pandemic brought a surge in alcohol consumption that hasn't slowed down. Dr. Brian Lee, a liver specialist, noticed more patients with severe liver issues due to excessive drinking. A recent study, led by Lee, found that alcohol use in the US increased in 2020 and kept rising in 2021 an

reading time less than a minute
Nov 24 2024CRIME

Drug Traffickers in Australia: How Many Quit After a First Conviction?

Most studies about drug traffickers focus on their crimes, but few look at their criminal careers. This study aimed to find out how many stop committing crimes after their first conviction for drug trafficking. It also wanted to know what makes drug traffickers likely to reoffend and how quickly, as

reading time less than a minute
Nov 24 2024BUSINESS

The Story Behind Nothing: A New Smartphone Venture

Meet Carl Pei, a 34-year-old entrepreneur who co-founded OnePlus. After leaving the company, he embarked on a new journey with Nothing—a smartphone venture. Why smartphones? Because, as Pei explains, they're the biggest consumer product in the world, with a billion sold each year. He believes that i

reading time less than a minute
Nov 24 2024HEALTH

Why Aren't All Kids in East Gojam, Ethiopia, Getting Vaccinated?

Vaccines save children's lives by keeping them safe from serious diseases. But in East Gojam, Amhara Region, Ethiopia, not all kids are getting the shots they need. A recent study looked into why this happens. It's not just about how much money families have, but also where they live, what they beli

reading time less than a minute
Nov 24 2024HEALTH

Reviving Old Medicine: A Fresh Fight Against COVID-19

You might be surprised to learn that scientists are turning to old drugs to combat COVID-19. Medicines like chloroquine, ivermectin, and remdesivir are being explored as potential weapons against the new coronavirus. These drugs aren't fresh off the assembly line, but they could be mighty effective

reading time less than a minute
Nov 24 2024HEALTH

Tweets Reveal Public Opinions on COVID-19 Drugs

Scientists have turned to Twitter to figure out what people really think about medicines used to treat COVID-19. They dug through over 600, 000 US tweets from January 2020 to November 2021, focusing on four drugs: Hydroxychloroquine and Ivermectin, which had some anecdotal support, and Molnupiravir

reading time less than a minute
Nov 24 2024ENVIRONMENT

Gold Mine Waste: How Particle Size Affects Water Pollution in Tanzania

Ever wondered how tiny pieces of rock from a gold mine can cause big problems? In Tanzania, waste rocks from gold mining are a real headache. Scientists tested different sizes of these rocks - from little ones smaller than a pea to big ones like a chicken egg. They found that tiny rocks can make the

reading time less than a minute
Nov 24 2024WEATHER

'Unpredictable Weather Ahead: Thanksgiving Travelers Beware! '

Listen up, travelers! This year's Thanksgiving might not be all about turkey and family gatherings. Forecasters are warning about some "yucky" weather that could interfere with your plans, especially if you're in the eastern part of the United States. Buckle up, because we might see some of the cold

reading time less than a minute
Nov 23 2024HEALTH

Exploring Fullerene B40 as a Drug Carrier for Lung Cancer Treatment

Scientists are diving into the world of nanomaterials to find better ways to deliver cancer drugs. One interesting substance is fullerene B40, a type of boron fullerene. Researchers used a method called DFT with B3LYP/6-311++G(d, p) to see how well B40 can carry a drug called gemcitabine, which figh

reading time less than a minute